Evotec’s Scientific Contributions
Visit our Focus Session
“Strategies for the development of allogenic iPSC-derived cell therapies"
Date and time: Thursday, 11 July 2024, 8.15-9.45 pm CEST
Location: Room: Hall Y7-12, Level 2
iPSCs can serve as starting material for generating potentially limitless amounts of cells for therapeutic applications, especially when focusing on allogenic, off-the-shelf approaches in regenerative and anti-tumor medicine. This session emphasizes distinct strategies for different categories of therapeutic cells, such as mature cells derived from organoids, cell clusters, and single-cell populations. Predictive and efficient functional assays both for cellular maturation and immune-evasion are essential to determine the chances of product success.
Agenda:
- Welcome and intro – Audrey Holtzinger and Matthias Austen, Evotec
- Harnessing the therapeutic potential of iPSC-derived immune cells to treat diseases of the lung and beyond – Nico Lachmann, Medizinische Hochschule, Hannover, Germany
- Precise identification of the blood forming cells in hPSC cultures – Andrea Ditadi, IRCCS Ospedale San Raffaele, Milan, Italy
- Transplantation of photoreceptors isolated from human iPSC-derived retinal organoids into mouse models of retinal degeneration – Marius Ader, Center for Regenerative Therapies Dresden (CRTD), Germany
Find our Focus Session within the ISSCR program: Link to program
Poster presentations
New Translational Screening Assay with Phenotypic and Transcriptomic Readouts using iPSC-derived Cells and Organoids from a Nephrotic Syndrome Patient
Presenting Author: Wenying Xian
Poster Session Date and Time: 10 July 2024; 6:45pm – 7.45pm CEST
Poster Board Number: 416
Session I: EVEN
Track: Disease Modeling and Drug Discovery (DMDD)
Immune-shielded and Safe iPSC-derived Cardiomyocytes for Heart Repair
Presenting Author: Katrin Ridders
Poster Session Date and Time: 10 July 2024; 5:45pm – 6.45pm CEST
Poster Board Number: 101
Session I: ODD
Track: Clinical Applications (CA)
Overcoming some of the Pitfalls of Retinal Organoid (RO) Culturing: Towards Large Scale Production
Presenting Author: Joana Ribeiro
Poster Session Date and Time: 10 July 2024; 6:45pm – 7.45pm CEST
Poster Board Number: 186
Session I: EVEN
Track: Clinical Applications (CA)
Further contributions
Christine Guenther to present "Focus Diabetes: the path of iPSC-derived beta cells to clinical application"
Contribution to BlueRock Focus Session Realizing the potential of PSC-derived therapies: From research to clinical translation
Date and time: Friday, 12 July 2024, 8.15-9.45 pm CEST
Location: Room: Hall Y7-12, Level 2
